Contrast enhancement agents and method of use thereof
    4.
    发明授权
    Contrast enhancement agents and method of use thereof 有权
    对比增强剂及其使用方法

    公开(公告)号:US09155804B2

    公开(公告)日:2015-10-13

    申请号:US13626942

    申请日:2012-09-26

    CPC classification number: A61K49/126

    Abstract: A contrast agent composition and a method of diagnostic imaging are provided. The composition comprises a pharmaceutically acceptable carrier and a metal-complex comprising a ligand having structure (XXX): wherein R1, R2, R3, R7, R8, R′1, R′2, R′3, R7′ and R8′ are selected form hydrogen, a protected C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group; R4, R′4 are selected from a hydrogen, a hydroxyl, a protected hydroxyl group, a protected C1-C3 hydroxyalkyl group, a C1-C3 alkyl group; n is an integer between 0 and 4; R5, R′5 are selected from a hydrogen, a protecting group comprising C1-C30 aliphatic radicals, C3-C30 cycloaliphatic radicals, C2-C30 aromatic radicals, m is an integer between 1 and 10; at least one of R7 and R′7 is acidic groups or protected acidic groups; Y comprises a protein or peptide moiety, a particle, a micelle, a liposome, an organic molecule, oligomer, polymer or a hydrophilic moiety.

    Abstract translation: 提供造影剂组合物和诊断成像方法。 该组合物包含药学上可接受的载体和包含具有结构(XXX)的配体的金属络合物:其中R1,R2,R3,R7,R8,R'1,R'2,R'3,R7'和R8'是 选自氢,受保护的C1-C3羟烷基或C1-C3烷基; R 4,R'4选自氢,羟基,被保护的羟基,保护的C 1 -C 3羟烷基,C 1 -C 3烷基; n是0和4之间的整数; R5,R'5选自氢,包含C1-C30脂族基团,C3-C30脂环族基团,C2-C30芳族基团的保护基,m是1-10之间的整数; R 7和R 7中的至少一个是酸性基团或被保护的酸性基团; Y包括蛋白质或肽部分,颗粒,胶束,脂质体,有机分子,低聚物,聚合物或亲水部分。

    CONTRAST ENHANCEMENT AGENTS AND METHOD OF USE THEREOF
    6.
    发明申请
    CONTRAST ENHANCEMENT AGENTS AND METHOD OF USE THEREOF 有权
    对比增强剂及其使用方法

    公开(公告)号:US20140086846A1

    公开(公告)日:2014-03-27

    申请号:US13626942

    申请日:2012-09-26

    CPC classification number: A61K49/126

    Abstract: A contrast agent composition and a method of diagnostic imaging are provided. The composition comprises a pharmaceutically acceptable carrier and a metal-complex comprising a ligand having structure (XXX): wherein R1, R2, R3, R7, R8, R′1, R′2, R′3, R7′ and R8′ are selected form hydrogen, a protected C1-C3 hydroxyalkyl group, or a C1-C3 alkyl group; R4, R′4 are selected from a hydrogen, a hydroxyl, a protected hydroxyl group, a protected C1-C3 hydroxyalkyl group, a C1-C3 alkyl group; n is an integer between 0 and 4; R5, R′5 are selected from a hydrogen, a protecting group comprising C1-C30 aliphatic radicals, C3-C30 cycloaliphatic radicals, C2-C30 aromatic radicals, m is an integer between 1 and 10; at least one of R7 and R′7 is acidic groups or protected acidic groups; Y comprises a protein or peptide moiety, a particle, a micelle, a liposome, an organic molecule, oligomer, polymer or a hydrophilic moiety.

    Abstract translation: 提供造影剂组合物和诊断成像方法。 该组合物包含药学上可接受的载体和包含具有结构(XXX)的配体的金属络合物:其中R1,R2,R3,R7,R8,R'1,R'2,R'3,R7'和R8'是 选自氢,受保护的C1-C3羟烷基或C1-C3烷基; R 4,R'4选自氢,羟基,被保护的羟基,保护的C 1 -C 3羟烷基,C 1 -C 3烷基; n是0和4之间的整数; R5,R'5选自氢,包含C1-C30脂族基团,C3-C30脂环族基团,C2-C30芳族基团的保护基,m是1-10之间的整数; R 7和R 7中的至少一个是酸性基团或被保护的酸性基团; Y包括蛋白质或肽部分,颗粒,胶束,脂质体,有机分子,低聚物,聚合物或亲水部分。

Patent Agency Ranking